05/12/2025
6:46 PM | Corvex Management LP (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Meister Keith A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:56 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4/A | |
05/09/2025
11:28 AM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
05/06/2025
8:45 PM | Corvex Management LP (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Meister Keith A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:48 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
PFENNIGER RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
6:44 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
6:46 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
6:02 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2025
6:04 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
8:51 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025
8:52 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for WGS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for GeneDx and its competitors with MarketBeat's FREE daily newsletter. |
04/16/2025
6:01 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2025
7:00 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2025
3:11 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
3:12 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
4:10 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2025
4:36 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
5:34 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2025
5:36 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
8:50 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
8:51 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
5:44 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
5:46 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
6:03 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2025
6:04 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2025
4:42 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:40 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
6:43 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
6:44 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
5:59 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:00 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2025
3:30 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Filed by)
| Form SCHEDULE 13D/A | |
02/20/2025
7:12 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form S-8 POS | |
02/20/2025
7:12 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form S-8 POS | |
02/20/2025
6:59 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
7:09 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/20/2025
7:11 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form S-8 POS | |
02/18/2025
7:01 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Filed by)
| Form SCHEDULE 13D/A | |
02/18/2025
5:50 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
3:26 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
01/31/2025
4:46 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s treachery (Ad) I think Trump’s Treasury Secretary is destroying the stock market on purpose.
And no one on Wall Street seems to understand why.
Like an addict who needs desperate help, Trump’s Treasury pick, Scott Bessent, is putting America through a “detox period” — and I think it’s going to be absolutely brutal for our economy.
Why’s he doing this? You may have already noticed the effect on your portfolio as markets have begun to bleed. |
01/31/2025
4:47 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
7:02 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
8:04 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2025
8:06 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2025
4:08 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
RUCH JOSHUA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
4:07 PM | Dechairo Bryan (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
11:55 AM | Dechairo Bryan (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/13/2025
7:36 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:53 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
4:54 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
4:02 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
3:44 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
5:04 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:05 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
4:14 PM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:31 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
5:21 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:22 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
7:40 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
7:41 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
6:18 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
6:19 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
7:05 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024
7:06 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
6:21 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
7:01 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/25/2024
5:21 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
7:21 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Ryan Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
7:23 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
RUCH JOSHUA (Reporting)
| Form 4/A | |
11/21/2024
5:14 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2024
8:36 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
OPKO HEALTH, INC. (Filed by)
| Form SC 13D/A | |
11/19/2024
7:00 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Filed by)
| Form SC 13D/A | |
11/19/2024
7:00 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
MOUNT SINAI HEALTH SYSTEM, INC. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
6:05 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
10:06 AM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
4:00 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Filed by)
| Form SC 13D/A | |
11/04/2024
4:01 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
MOUNT SINAI HEALTH SYSTEM, INC. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
7:03 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
4:14 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
4:13 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
6:44 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
6:45 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:10 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:18 AM | GeneDx Holdings Corp. (Filer)
GeneDx (Filer)
GeneDx Holdings Corp. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/17/2024
4:47 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Ryan Jason (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2024
4:41 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
RUCH JOSHUA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
1:56 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
OPKO HEALTH, INC. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:26 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:13 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
OPKO HEALTH, INC. (Filed by)
| Form SC 13D/A | |
09/16/2024
5:54 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Is President Trump Lying To You With This? (Ad) President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse?
The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity. Protect your IRA—Trump’s warning was real |
09/16/2024
5:54 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
7:10 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
Stueland Katherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
7:14 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:03 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
Stueland Katherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
8:03 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
7:10 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
8:35 PM | Feeley Kevin (Reporting)
GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
4:33 PM | GeneDx Holdings Corp. (Subject)
GeneDx (Subject)
GeneDx Holdings Corp. (Subject)
OPKO HEALTH, INC. (Filed by)
| Form SC 13D/A | |
08/19/2024
4:23 PM | GeneDx Holdings Corp. (Issuer)
GeneDx (Issuer)
GeneDx Holdings Corp. (Issuer)
OPKO HEALTH, INC. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
